MorphoSys AG buy mohabbatein
Summary
This prediction ended on 29.10.18 with a price of €81.15. The BUY prediction by mohabbatein for MorphoSys AG closed nearly unchanged. mohabbatein has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
MorphoSys AG | -0.148% | -0.148% | 141.435% | 6.872% |
iShares Core DAX® | 0.443% | 0.771% | 16.335% | 15.985% |
iShares Nasdaq 100 | -0.150% | 4.094% | 36.047% | 50.709% |
iShares Nikkei 225® | 2.566% | 4.202% | 15.033% | 10.588% |
iShares S&P 500 | 0.479% | 2.881% | 29.113% | 45.053% |
Comments by mohabbatein for this prediction
In the thread Morphosys AG diskutieren
mohabbatein stimmt dem Sentiment von 'Sell' nicht zu
mohabbatein stimmt am 15.10.2018 dem Sell-Gesamtsentiment mit dem Kursziel 74.3€ nicht zu.
Auch hier nutze ich das aktuell miese Börsensentiment und den kräftigen Kurssturz der besten deutschen Biotech-Schmiede zum Einstieg. Die Pipeline von Morphosys ist prall gefüllt. Gute NEws nur ein Frage der Zeit.
BUY.